BioSpace News Archive

Newronika, a spin-off of the world-class neurological research center Policlinico of Milan and University of Milan, today announced the first patient implanted with the AlphaDBS adaptive closed-loop deep brain stimulation (aDBS) system. Closed-loop stimulation is the most important advancement in the DBS field to date.

I-Mab (the “Company”) (NASDAQ: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed in a phase 2 clinical trial ( NCT04600817 ) of TJ107 (efineptakin alpha), a novel long-acting reco

Slayback Pharma LLC announces that it has launched Merzee (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1 mg/20 mcg and fulfilled customer orders for the product. With the launch, Slayback has effectively secured 180-day period of CGT exclusivity.

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial results for its third quarter fiscal year 2021, ended December 31, 2020 , at 4:15 p.m. EST on Wednesday, February 10, 2021 .

Nonprofit alliance behind gold standard oncology guidelines shares stories of personal connections to cancer that inspire many within the organization.

Novo Integrated Sciences, Inc. (OTCQB:NVOSD) (OTCQB:NVOS) (the “Company”), a U.S.-based provider of multi-dimensional primary healthcare services in Canada; and Novo Healthnet Limited (“NHL”), a wholly owned Canadian subsidiary of the Company, announced today Mr. James Asher has been appointed as President, NHL

Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, announced the pricing of its previously announced underwritten public offering of 3,571,428 shares of its common stock at a public offering price of $70.00 per share.

Innocoll Holdings Limited, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced today that Anthony Galdi has been named the Chief Commercial Officer of the Innocoll Group of Companies, effective mid-February. Galdi succeeds Jim Helm, who is retiring and has agreed to assist with the leadership transition. This press release features multimedia. View the full release here: https

Neutra Corp. (OTC PINK: NTRR ) has decided to release a statement that management does not plan on having a share consolidation, also known as a reverse split at this time. Instead, the Company will focus on the growth of its wholly owned subsidiary VIVIS CBD.

Bristol Myers Squibb Reports Fourth Quarter Revenues of $11.1 Billion; Full-Year Revenues of $42.5 Billion Posts Fourth Quarter Loss Per Share of $4.45 and Non-GAAP EPS of $1.46; Full-Year Loss Per Share of $3.99 and Non-GAAP EPS of $6.44 Completes Acquisition of MyoKardia, Expanding Leading Cardiovascular Franchise